Associates of Cape Cod, Inc.
Testing Excellence
News
Associates of Cape Cod, Inc. to Hold Ribbon-Cutting Ceremony for New State-of- the-Art Manufacturing Facility on Cape Cod
EAST FALMOUTH, MA., Sept. 20, 2004 /Associates of Cape Cod,
Inc. (ACC), the largest biotechnology company on the Cape, will celebrate the completion of its new 83,000 square foot facility during a ribbon-cutting ceremony on Friday, September 24, 2004. ACC is a leading analyte detection company and manufacturer of endotoxin and beta-glucan detection products and a major supplier to the pharmaceutical and medical device industries, as well as one of the largest biotechnology companies on the Cape.
The ceremony will begin at 10:30 a.m. at the site of Associates of Cape Cod's new headquarters, 124 Bernard E. St. Jean Drive. Invitees will be offered building tours, which will highlight the facility's fully integrated, FDA-licensed, GMP cleanroom suite at the completion of the ceremony, as well as a reception for all attendees.
ACC recently received FDA approval to manufacture three of its highest- profile products, Pyrotell® Single Test Vial, Pyrotell® 5mL and Pyrotell®-T, at the new Falmouth Technology Park facility. Also, the Company's brand-new Clinical Diagnostic Laboratory, Beacon Diagnostics<®Laboratory, has been licensed by the Commonwealth of Massachusetts and registered as a CLIA laboratory by the Centers for Medicare and Medicaid Services. Beacon Diagnostics® Laboratory will initially perform testing for invasive fungal infection in patient serum using Fungitell®.
"Associates of Cape Cod's new home symbolizes our deep-rooted commitment to growing our business to meet the ever-changing needs of our customers," said Dr. A.J. Meuse, ACC's president and chief executive officer. "We've made a conscious decision to stay on the Cape, where our Company began thirty years ago, and are excited about the opportunities that the new facility has created. We hope that the members of the staff, community and government will join us in celebrating the start of the next phase of Associates of Cape Cod's growth."
About Associates of Cape Cod, Inc.
Associates of Cape Cod, Inc., based in Falmouth, MA, is a leader in the field of bacterial endotoxin and beta-glucan detection. A wholly owned subsidiary of Seikagaku Corporation, the Company pioneered the use of Horseshoe Crab blood extract, Limulus Amebocyte Lysate (LAL), used in the testing of pharmaceuticals, medical devices and biologics, for the presence of potentially toxic endotoxins and glucans. In 1977 the Company was the first to receive an FDA license for the manufacture of this reagent. Our products are marketed throughout the world under the trade names Pyrotell®, Glucatell®, Pyrochrome® and Chromo-LAL. The Company also offers contract testing for endotoxins and glucans, and has a research biochemicals division, Seikagaku America, specializing in carbohydrate chemistry.